Specifically, SMYD5 exhibited a mutation frequency of 2.3% in colorectal cancer, while SMYD1 demonstrated a mutation frequency of 2.3% in both lung adenocarcinoma and lung squamous cell carcinoma. This evidence concerns the gene SMYD1 and squamous cell lung carcinoma.